Pricing Log in Create free account

Precision BioSciences, Inc. (DTIL) vs Oramed Pharmaceuticals Inc. (ORMP)

Precision BioSciences, Inc. and Oramed Pharmaceuticals Inc. are both Biotechnology companies. Precision BioSciences, Inc. and Oramed Pharmaceuticals Inc. are of similar size ($173.9M and $170.3M). Precision BioSciences, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 347.8% against −11.9%. Across the 15 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and Precision BioSciences, Inc. on 7.

Valuation

Metric DTIL ORMP Biotechnology median
P/E n/m 0.96 8.50
P/S 3.31 41.54 9.71
P/B 3.29 0.53 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.87 28.95 9.21
Earnings yield (48.35%) 103.93% (33.15%)
Free cash flow yield (35.07%) (3.12%) (25.50%)

Profitability

Metric DTIL ORMP Biotechnology median
Gross margin 100.00% 32.31% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (132.91%) 73.90% (56.36%)
Return on assets (44.91%) 65.52% (48.04%)
Return on invested capital 0.00% (3.40%) 0.00%

Growth

Metric DTIL ORMP Biotechnology median
Revenue growth (TTM) (11.87%) 347.77% 6.02%
EPS growth (last fiscal year) (442.31%) 412.50% 30.26%
Revenue growth, 5-year CAGR 7.13% (5.85%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DTIL ORMP Biotechnology median
Debt to equity 0.50 0.00 0.00
Current ratio 12.82 4.98 4.72
Net debt to EBITDA 1.86 8.41 0.96

Dividend

Metric DTIL ORMP Biotechnology median
Dividend yield — 6.14% 0.09%
Payout ratio — 0.06 —

Size

Metric DTIL ORMP Biotechnology median
Market cap 170.30m 173.87m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack